BM
Bristol-Myers Squibb
BMY13F as of Jun 30, 2026 · next update ~Nov 14
Who's buying BMY
Top funds were split on Bristol-Myers Squibb in Q2 (Apr–Jun)
Buying:
FundsInsidersCongress
- Top funds3 of 8 bought more, 4 sold some. Largest: Pzena Investment Management, $979.9M (3% of its portfolio).
- InsidersNo buys, 3 sales in 12 months.
- Congress1 member bought (1 trade), 2 sales in 12 months.
8 funds$1.0B held1.0% avg. weightQ2: 3 bought / 4 sold
13F reports are a snapshot as of Jun 30, 2026; funds may have traded since. Insiders often sell for personal reasons (taxes, diversification, planned sales).
Share price · market data, not from 13F reports
Q2 2026